ose veins. Br J Surg 2009;96:369-75.
El-Sheikha J, Nandhra S, Carradice D, Wallace T, Samuel N,
Smith GE, et al. Clinical outcomes and quality of life 5 years after a
randomized trial of concomitant or sequential phlebectomy
following endovenous laser ablation for varicose veins. Br J Surg
2014;101:1093-7.
Conway RG, Almeida JI, Kabnick L, Wakeﬁeld TW, Buchwald AG,
Lal BK. Clinical response to combination therapy in the treatment
of varicose veins. J Vasc Surg Venous Lymphat Disord 2020;8:216-23.
Brown CS, Obi AT, Cronenwett JL, Kabnick L, Wakeﬁeld TW,
Osborne NH. Outcomes after truncal ablation with or without
concomitant phlebectomy for isolated symptomatic varicose
veins (C2 disease). J Vasc Surg Venous Lymphatic Disord 2021;9:
369-76.

118. Hager ES, Ozvath KJ, Dillavou ED. Evidence summary of combined
saphenous ablation and treatment of varicosities versus staged
phlebectomy. J Vasc Surg Venous Lymphat Disord 2017;5:134-7.
119. van Neer PKA, de Haan E, Estourgie R, Veraart J, Lijnen R,
Neumann M. Residual varicose veins below the knee after varicose
vein surgery are not related to incompetent perforating veins. J Vasc
Surg 2006;44:1051-4.
120. Gibson K, Kabnick L. A multicenter, randomized, placebocontrolled study to evaluate the efﬁcacy and safety of VarithenaÒ
(polidocanol endovenous microfoam 1%) for symptomatic, visible
varicose veins with saphenofemoral junction incompetence.
Phlebology 2017;32:185-9